Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GOZZETTI, A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 11 of 11

  • Page / 1
Export

Selection :

  • and

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myelomaCAVO, M; BANDINI, G; MOTTA, M et al.Bone marrow transplantation (Basingstoke). 1998, Vol 22, Num 1, pp 27-32, issn 0268-3369Article

Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemiaZINZANI, P. L; LAURIA, F; RUSSO, D et al.European journal of haematology. 1993, Vol 51, Num 2, pp 93-97, issn 0902-4441Article

Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridizationSANCHEZ-IZQUIERDO, D; SIEBERT, R; SONOKI, T et al.Leukemia. 2001, Vol 15, Num 9, pp 1475-1484, issn 0887-6924Article

FLU-ID (fludarabine and idarubicin) regimen as salvage therapy in pretreated low-grade non-Hodgkin's lymphomaZINZANI, P. L; BENDANDI, M; GHERLINZONI, F et al.Haematologica (Roma). 1996, Vol 81, Num 2, pp 168-171, issn 0390-6078Article

Primary plasma cell leukemia: a retrospective multicenter study of 73 patientsPAGANO, L; VALENTINI, C. G; FERRARA, F et al.Annals of oncology. 2011, Vol 22, Num 7, pp 1628-1635, issn 0923-7534, 8 p.Article

Behavioral syndromes in Alzheimer's disease : Description and correlatesFRISONI, G. B; ROZZINI, L; GOZZETTI, A et al.Dementia and geriatric cognitive disorders. 1999, Vol 10, Num 2, pp 130-138, issn 1420-8008Article

The role of haematopoietic stem cell-supported myeloablative therapy for the management of multiple myelomaCAVO, M; BENNI, M; GOZZETTI, A et al.Baillière's clinical haematology. 1995, Vol 8, Num 4, pp 795-813, issn 0950-3536Article

Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial. CommentaryBOCCHIA, M; GENTILI, S; AMADORI, S et al.Lancet (British edition). 2005, Vol 365, Num 9460, pp 631-632, issn 0140-6736, 8 p.Article

An unusual presentation of chronic B-cell lymphocytic leukaemiaFABBRI, A; GOZZETTI, A; MAROTTA, G et al.British journal of haematology. 2004, Vol 124, Num 2, issn 0007-1048, p. 129Article

Cytokeratin-positive interstitial cell neoplasm: a case report and classification issuesSCHUERFELD, K; LAZZI, S; DE SANTI, M. M et al.Histopathology. 2003, Vol 43, Num 5, pp 491-494, issn 0309-0167, 4 p.Article

Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphomaZINZANI, P. L; LAURIA, F; RUSSO, D et al.Annals of oncology. 1993, Vol 4, Num 7, pp 575-578, issn 0923-7534Article

  • Page / 1